SBIR Phase I: Detection and Determination of Viability of Cryptospordium oocysts by Capillary Column Immunosensor

Period of Performance: 01/01/2010 - 12/31/2010


Phase 1 SBIR

Recipient Firm

Biodetection Instruments, LLC
Fayetteville, AR 72701
Principal Investigator


This SBIR Phase I project will develop a method to detect Cryptosporidium oocysts at a level of 100 oocysts/L or lower, and to differentiate between viable and non-viable cysts. The team will use a prototype of a capillary-based immunosensor (AEGIS 1000 instrument) coupled with heat and lysis treatment to detect Cryptosporidium in water.